Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy

More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!

“…6,10 When taken together with clinical and laboratory findings, echocardiography is a highly important tool for risk stratification, as abnormal values for many echocardiographic parameters have been correlated with reduced event-free survival. 11 As such, it is critical for the cardiology community to advocate for early echocardiographic evaluation in any patient with possible signs and symptoms of heart failure. From phenotyping and choosing appropriate medical therapy to aiding in patient prognostication, there are multiple important reasons to bolster rates of echocardiography in the heart failure population.…”